消息面上，栢能集团公布，撤回上市的决议已获股东投票正式通过，预计股份于港交所买卖最后日期为 2026年1月8日。据悉，公司于9月12日向港交所提交申请，从港交所主板自愿撤回股份上市。公司从港 交所除牌后将保留其股份于新加坡交易所现有主要上市地位。公开资料显示，栢能集团为全球第二大 GPU显卡生产厂，旗下的索泰品牌为英伟达全球核心AIC合作伙伴。 栢能集团(01263)现涨近5%，截至发稿，涨4.82%，报6.53港元，成交额2053.92万港元。 ...

Core Viewpoint - Nvidia's new GeForce RTX 50 series graphics cards are experiencing high demand, significantly exceeding supply, with retail prices up to 50% above the official suggested price [1] Group 1: Nvidia and RTX 50 Series - The RTX 5090 graphics card is currently priced over $3000 in the market, maintaining a high premium [1] - The RTX 5090 and RTX 5080 feature significant technical improvements over the previous generation, including the latest Ada Lovelace architecture, enhanced graphics processing capabilities, and support for ultra-high resolutions [1] - The VRAM for the RTX 5090 has been increased to 24GB, enhancing gaming graphics and performance [1] Group 2: Company Performance and Market Outlook - According to GF Securities, the shipment volume of the RTX 50 series is expected to reach 35-40 million units by 2025, representing a growth of over 30% compared to the previous RTX 40 series [2] - Biostar Group, a major GPU manufacturer, reported a revenue of 10.082 billion yuan for 2024, a 10% increase year-on-year, with a net profit of 262 million yuan, up 331% [2] - The strong demand for new graphics cards and reduced promotional expenses contributed to improved gross margins for Biostar Group [2] Group 3: Profitability and Valuation - If the RTX 5090 accounts for 5% of the RTX 50 series shipments, Biostar Group could see a net profit contribution of approximately 512 million HKD from this product alone, nearly doubling its 2024 net profit [3] - Biostar Group has recently partnered with Supermicro and is entering the Chinese cloud service supply chain, which may provide new growth opportunities [3] - The company's stock is currently trading at a PE ratio of only 4 times for 2025, significantly lower than competitors like Asus (12 times) and MSI (13 times), indicating substantial valuation recovery potential [3]